Literature DB >> 33751313

Use of Pre-exposure Prophylaxis Among People Who Inject Drugs: Exploratory Findings of the Interaction Between Race, Homelessness, and Trust.

Xin Zhou1, Frederick L Altice2,3, Divya Chandra2,4, Elizabeth Didomizio2, Michael M Copenhaver3,5, Roman Shrestha2,3.   

Abstract

Scale-up of pre-exposure prophylaxis (PrEP) in people who inject drugs (PWID) remains suboptimal. Patient-level factors are often complex and may contribute to scale-up. Using cross-sectional data from 234 opioid-dependent patients on methadone who met eligibility criteria for PrEP, we conducted logistic regression analyses to assess potential moderators associated with being on PrEP (n = 60). Mean provider trust was significantly higher among Blacks vs Whites (39.4 vs 34.9; p = 0.002) and non-homeless vs homeless participants (37.5 vs 34.8; p = 0.008). Though race/ethnicity was not a significant moderator on provider trust and PrEP use, increased provider trust was marginally associated with increased PrEP use among Blacks (p = 0.058). Additionally, homelessness significantly moderated provider trust and PrEP use (p = 0.024). Provider trust among non-homeless participants was positively correlated with PrEP use (p = 0.013) but not among homeless participants. Strategies that promote provider trust in Blacks and non-homeless PWID on methadone may improve PrEP scale-up.

Entities:  

Keywords:  Ethnic disparities; Methadone maintenance treatment; People who inject drugs (PWID); Pre-exposure prophylaxis (PrEP); Provider trust

Year:  2021        PMID: 33751313     DOI: 10.1007/s10461-021-03227-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  35 in total

1.  Opioids and Infectious Diseases: A Converging Public Health Crisis.

Authors:  Tara A Schwetz; Thomas Calder; Elana Rosenthal; Sarah Kattakuzhy; Anthony S Fauci
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

2.  Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.

Authors:  Willi McFarland; Jessica Lin; Glenn-Milo Santos; Sean Arayasirikul; Henry Fisher Raymond; Erin Wilson
Journal:  AIDS Behav       Date:  2020-05

3.  PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.

Authors:  Susan G Sherman; Kristin E Schneider; Ju Nyeong Park; Sean T Allen; Derrick Hunt; C Patrick Chaulk; Brian W Weir
Journal:  Drug Alcohol Depend       Date:  2018-10-22       Impact factor: 4.492

4.  Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.

Authors:  Irene Kuo; Halli Olsen; Rudy Patrick; Gregory Phillips; Manya Magnus; Jenevieve Opoku; Anthony Rawls; James Peterson; Flora Hamilton; Michael Kharfen; Alan Greenberg
Journal:  Drug Alcohol Depend       Date:  2016-03-15       Impact factor: 4.492

5.  Homelessness, HIV, and Incomplete Viral Suppression.

Authors:  Kinna Thakarar; Jake R Morgan; Jessie M Gaeta; Carole Hohl; Mari-Lynn Drainoni
Journal:  J Health Care Poor Underserved       Date:  2016-02

6.  Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004-2013.

Authors:  Christopher M Jones; Aleta Christensen; R Matthew Gladden
Journal:  Drug Alcohol Depend       Date:  2017-05-16       Impact factor: 4.852

7.  Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.

Authors:  Anita Palepu; M-J Milloy; Thomas Kerr; Ruth Zhang; Evan Wood
Journal:  J Urban Health       Date:  2011-06       Impact factor: 3.671

8.  Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment.

Authors:  Roman Shrestha; Michael Copenhaver
Journal:  Front Public Health       Date:  2018-07-13

Review 9.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

Authors:  Georgie J MacArthur; Silvia Minozzi; Natasha Martin; Peter Vickerman; Sherry Deren; Julie Bruneau; Louisa Degenhardt; Matthew Hickman
Journal:  BMJ       Date:  2012-10-03

10.  HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016.

Authors:  Ya-Lin A Huang; Weiming Zhu; Dawn K Smith; Norma Harris; Karen W Hoover
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-10-19       Impact factor: 17.586

View more
  2 in total

1.  Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment.

Authors:  Christopher Brokus; Sarah Kattakuzhy; Britt Gayle; Shivakumar Narayanan; Ashley Davis; Amelia Cover; Rahwa Eyasu; Emade Ebah; Onyinyechi Ogbumbadiugha-Weekes; Jennifer Hoffmann; Rachel Silk; Jasmine Stevens; Julia Mount; Catherine Gannon; Laura Nussdorf; Poonam Mathur; Phyllis Bijole; Miriam Jones; Randy Kier; David Sternberg; Aaron Greenblatt; Eric Weintraub; Henry Masur; Shyamasundaran Kottilil; Elana Rosenthal
Journal:  Open Forum Infect Dis       Date:  2021-12-29       Impact factor: 3.835

2.  Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.

Authors:  Adrian R King; Saanchi Shah; Laura A Randall; Paula M Frew; Anne Spaulding; Ian W Holloway
Journal:  BMC Infect Dis       Date:  2022-09-14       Impact factor: 3.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.